Treatment with GLP-1 receptor agonists can reduce disease activity, relieve pain, and improve cardiovascular health in patients with rheumatoid arthritis and overweight or obesity.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/glp-1s-benefit-patients-ra-and-overweight-or-obesity-2025a1000pep?src=rss
Author :
Publish date : 2025-09-23 18:53:00
Copyright for syndicated content belongs to the linked Source.
